NCT06634069View on ClinicalTrials.gov

Study SOLACE SEPSIS

PHASE2RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 24, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions

Septic ShockIntracranial Hypertension

Interventions

DRUG

Sodium Lactate

0.5M HSL (containing 504mM of sodium and lactate)

DRUG

3% NaCl

active compartor 3% NaCl

Trial Locations (1)

30100

RECRUITING

University Hospital Pilsen, Pilsen

All Listed Sponsors

lead

University Hospital Pilsen

OTHER